We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Shuttout is a global community-driven photography marketplace that adds social significance to photographs and makes it more fit for sale. It uses features such as 'stock' (Shutterstock, 500px, Flickr), 'social media' (Instagram) and 'photo contest' (GuruShots, Viewbug) to create a unique selling environment. It started worldwide expansion, growth and user acquisition from 154 countries using Facebook and Google ads. It has also collaborated with YouTube Influencers including Rebecca Spencer (UK), Hanna Saba (Australia), and Saurav Sinha (India) to increase its userbase. Shuttout has started the facility for users to host contests by themselves. Since the launch in April 2018, it has reached 76,000+ users and has added 71,000+ photos to the platform. The platform aims to connect those who love taking photos and want to earn money from their passion with potential buyers. 
days to go: Expired investment: £539,536
SMA Building and Maintenance Solution Ltd is an environmentally conscious company. based in Gloucester and was founded in 2019 by Suzanne Ackland. They serve a diverse clientele, including renowned brands like Ted Baker, Primark, Co-Op, and Barratt Developments. By combining their expertise, innovation, and unwavering commitment to quality, they create lasting and inspiring spaces. The company is presently in search of funds to support its expansion and refinancing efforts.
days to go: Expired investment: £53,000
Pioneering medical device company with patented technologies in the "key hole" surgery market 
days to go: Expired investment: £600,083
SpaceX is an aerospace manufacturer and space transportation services company founded in 2002 by Elon Musk that aims to reduce space transportation costs and eventually enable the colonisation of Mars. The company has developed several launch vehicles, rocket engines and Autonomous Spaceport Drone Ship (ASDS) landing platforms. Its project, Falcon 9, became the first rocket to accomplish a propulsive vertical landing in December 2015. As of March 2018, SpaceX had over 100 launches on its manifest representing about $12 billion (£9.24 billion) in contract revenue. The company has also ventured into providing satellite internet access by launching its Starlink project. As of 13th June 2020, it has launched 540 Starlink satellites. It will soon launch its Interplanetary Transport System (ITS), Starship, to further inter-planetary travel and colonisation. They will use the investment to grow its projects across various verticals.
days to go: Expired investment: £8,752,000
Stablepharma invents a disruptive solution that can eliminate waste and supply life-saving vaccines without refrigeration. It is a patented invention that allows vaccines to be stored for years and transported without refrigeration whilst adhering with the protocols established by the WHO. Its current project plan comprises the Tetanus vaccine processed by Clinical Trials in Humans. The success of this project will significantly enhance the value of the invention and allow it to set up a pilot scale production in the $36 bn human vaccine market.
days to go: Expired investment: £1,310,090
Stagedoor is a new generation theatre guide and hassle-free booking platform. It is London's first discovery-led theatre application which makes purchasing theatre tickets easy. Stagedoor is the official application for the Camden Fringe and VAULT Festival, and currently, it's having discussions to bring Stagedoor to the Edinburgh Festival. The user growth of the company has increased and reached 53,000 downloads. Furthermore, it has raised 730K from angel investors & an EU innovation grant. Stagedoor will use the funds raised in growing its user base and in improving its application and website.
days to go: Expired investment: £193,450
Stericile Ltd is a chemical R&D company that has scientifically created a disinfectant meant to combat the epidemic of Hospital Acquired Infections. The company has achieved the biggest technological advancement in the peracetic acid market, having spent over £400,000 to create a unique chemical solution for the healthcare market. Stericile Ltd has secured a UK national supplier that caters to 15,000+ healthcare customers such as dentist & doctor surgeries, care homes, and medical centres with less effective products.
days to go: Expired investment: £229,200
SuperCarers is an online platform that helps families to find trusted carers living in their local area. SuperCarers do not have the high overhead costs of agencies and therefore enable supercarers to be paid significantly more than the national living wage. 
days to go: Expired investment: £1,079,495
The world's first automated suturing tools for safe closure of standard and endoscopic wounds. Sutrue have already patented their devices and use industry-standard needles to offer clinical quality with improved speed and accuracy at the touch of a button. Needles are held in disposable cartridges as a safety feature to prevent injury when piercing skin with contaminated needles. This protects staff both during and after surgery for those working in medical and veterinary environments. Sutrue is raising finance for the production process of their equipment, as well as applying for CE regulation via medical evaluations to receive approval to deploy their products in human and animal surgeries.
days to go: Expired investment: Withheld
Swiss-licensed medical cannabis producer, swisscann, targets the expansive €12 billion global medical cannabis market, with an EU distribution agreement already secured. Leveraging its THC-licensed production facility, the company aims to meet the rising demand for safe and effective medical cannabis products, boasting a cultivation license and a partnership with a publicly listed European pharmaceutical distributor. Strategically headquartered in Zurich, Switzerland, swisscann benefits from proximity to Germany, Europe's largest medical cannabis market projected to reach multibillion-Euro valuations by 2027. Anticipating availability in European pharmacies and an initial launch in the German market by Q1 2024, swisscann aims to establish its foothold in the European medical cannabis landscape.
days to go: Expired investment: £1,067,294
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph